Watchlist Manager

Watchlist

Price: 17 840 KRW -1.71%

Market Cap: ₩223.5B

S	Samjin Pharmaceutical Co Ltd KRX:005500	KR
T	Telesat Corp TSX:TSAT	CA
F	Finnair Oyj OMXH:FIA1S	FI
	PC Connection Inc NASDAQ:CNXN	US

Balance Sheet

Currency: KRW

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	2 392	3 967	1 494	1 859	1 715	1 669	1 356	6 339	1 806	1 191	2 338	2 491	2 579	2 693	886	11 910	21 914	30 699	31 896	18 910	7 941	2 341	2 401	3 417
Cash	0	0	0	0	0	0	0	0	0	0	0	121	284	293	381	342	330	199	31	50	34	86	58	32
Cash Equivalents	2 392	3 967	1 494	1 859	1 715	1 669	1 356	6 339	1 806	1 191	2 338	2 370	2 295	2 400	505	11 568	21 584	30 500	31 865	18 860	7 907	2 256	2 343	3 385
Short-Term Investments	901	581	1 851	867	2 243	14 295	2 107	2 270	3 440	5 789	2 780	7 427	5 372	3 500	3 890	7 120	6 500	4 655	5 390	5 580	3 770	2 321	1 605	288
Total Receivables	27 883	31 056	39 705	48 427	61 665	79 094	94 227	102 034	102 293	119 131	116 212	96 970	94 325	87 132	88 754	83 784	76 499	64 201	53 334	51 429	57 684	59 883	61 455	62 673
Accounts Receivables	27 803	31 045	39 705	48 360	61 582	79 022	94 171	101 802	101 130	119 029	116 159	96 554	93 980	86 860	88 598	83 733	76 390	64 071	53 222	51 414	56 791	59 838	60 131	62 525
Other Receivables	80	11	0	67	83	72	56	232	1 163	102	53	416	345	272	156	51	109	130	112	15	894	45	1 324	148
Inventory	9 614	11 634	14 594	17 319	16 589	14 762	12 760	18 765	23 253	25 123	24 148	26 061	28 458	33 933	43 054	42 312	51 437	61 724	58 032	70 065	69 709	68 595	79 603	91 736
Other Current Assets	996	1 215	641	597	602	609	834	825	1 632	247	147	388	623	1 106	625	713	921	2 232	1 459	876	768	1 128	1 117	991
Total Current Assets	41 786	48 454	58 285	69 069	82 813	110 429	111 284	130 234	132 425	151 482	145 626	133 336	131 357	128 365	137 209	145 839	157 271	163 511	150 110	146 860	139 872	134 268	146 180	159 105
PP&E Net	21 156	19 985	25 522	30 663	32 382	35 629	36 541	37 288	43 480	44 593	52 734	61 382	62 881	70 017	71 146	72 398	74 868	71 199	75 260	102 526	168 901	198 068	191 640	192 505
PP&E Gross	21 156	19 985	25 522	30 663	32 382	35 629	36 541	37 288	43 480	44 593	52 734	61 382	62 881	70 017	71 146	72 398	74 868	71 199	75 260	102 526	168 901	198 068	191 640	192 505
Accumulated Depreciation	7 088	8 736	10 125	12 033	13 875	15 789	17 431	19 348	21 577	23 724	26 661	30 301	35 502	41 485	47 987	54 864	58 413	61 215	56 321	74 457	79 485	88 226	102 881	116 358
Intangible Assets	4 696	4 977	5 697	5 256	6 254	6 222	6 329	6 289	6 241	2 275	2 332	2 223	2 132	2 870	3 949	3 923	3 970	4 237	7 518	8 496	10 313	10 340	20 300	21 524
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	634	784	0	0	0	0	0
Long-Term Investments	743	1 540	1 388	2 167	2 163	2 072	2 553	3 641	4 578	2 854	6 200	6 533	6 704	7 189	7 736	4 610	4 666	10 298	9 431	8 031	10 333	63 329	58 065	42 264
Other Long-Term Assets	413	485	515	515	1 080	964	1 014	1 121	894	1 070	1 212	711	871	866	696	803	1 072	2 761	1 047	3 120	3 077	553	3 716	9 769
Total Assets	68 795 N/A	75 441 +10%	91 407 +21%	107 669 +18%	124 691 +16%	155 315 +25%	157 721 +2%	178 573 +13%	187 618 +5%	202 273 +8%	208 104 +3%	204 186 -2%	203 946 0%	209 306 +3%	220 736 +5%	227 573 +3%	241 847 +6%	252 639 +4%	244 151 -3%	269 033 +10%	332 496 +24%	406 557 +22%	419 901 +3%	425 166 +1%
Liabilities
Accounts Payable	1 927	1 392	2 472	2 312	2 149	2 148	2 606	2 957	2 472	16 289	15 732	19 428	12 028	16 150	15 546	20 507	21 422	17 947	15 667	12 710	12 236	13 180	11 137	16 282
Accrued Liabilities	1 126	1 329	1 424	2 552	2 819	2 509	3 010	2 833	3 980	3 897	3 348	2 594	3 545	2 920	4 015	4 118	4 058	3 974	3 645	3 238	4 990	7 281	7 960	7 008
Short-Term Debt	0	0	8 450	16 800	11 630	17 100	18 842	30 919	34 300	30 000	41 440	43 000	47 500	33 000	29 000	9 000	4 000	0	0	0	10 000	36 000	75 500	91 000
Current Portion of Long-Term Debt	410	450	438	474	388	8 000	11 013	8 013	19 000	8 000	3 000	0	0	0	0	0	0	0	785	1 060	4 518	8 842	38 814	29 829
Other Current Liabilities	5 675	4 519	5 526	7 214	5 442	7 274	6 307	7 481	4 088	7 483	6 194	5 706	8 159	11 770	9 398	13 039	13 726	16 433	10 611	16 927	17 770	16 349	11 139	15 011
Total Current Liabilities	9 138	7 690	18 310	29 352	22 429	37 032	41 778	52 204	63 840	65 669	69 714	70 728	71 232	63 839	57 959	46 664	43 206	38 354	30 707	33 935	49 514	81 652	144 550	159 130
Long-Term Debt	1 899	1 305	863	389	16 090	11 013	6 000	9 000	0	3 000	0	0	0	0	0	0	0	0	704	7 215	39 988	42 671	4 324	593
Deferred Income Tax	191	874	1 351	1 112	703	808	1 090	0	150	519	1 095	1 982	2 851	2 165	2 025	406	0	0	0	0	0	1 145	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	520	0	0
Other Liabilities	5 135	5 964	7 846	8 874	10 939	13 364	11 448	14 468	14 044	15 826	17 415	18 736	16 879	17 260	12 689	10 809	5 174	16 381	15 265	14 427	8 826	5 225	5 662	3 788
Total Liabilities	16 363 N/A	15 834 -3%	28 369 +79%	39 726 +40%	50 160 +26%	62 217 +24%	60 316 -3%	75 672 +25%	78 034 +3%	85 013 +9%	88 224 +4%	91 446 +4%	90 963 -1%	83 265 -8%	72 673 -13%	57 878 -20%	48 380 -16%	54 735 +13%	46 677 -15%	55 577 +19%	98 328 +77%	131 213 +33%	154 536 +18%	163 511 +6%
Equity
Common Stock	11 000	11 000	11 000	11 000	11 000	12 500	12 500	12 750	13 120	13 500	13 900	13 900	13 900	13 900	13 900	13 900	13 900	13 900	13 900	13 900	13 900	13 900	13 900	13 900
Retained Earnings	16 661	23 836	28 964	35 263	41 851	48 699	53 005	58 304	64 617	84 832	89 282	82 282	84 425	108 086	129 106	149 818	177 620	184 244	182 940	198 694	219 405	239 551	229 204	246 137
Additional Paid In Capital	13 658	13 658	13 658	13 658	13 658	23 877	23 877	23 877	23 877	23 877	23 877	24 037	24 973	25 866	26 721	27 593	28 440	29 246	30 013	23 877	23 877	23 877	23 877	23 877
Unrealized Security Profit/Loss	12 882	12 882	12 882	12 882	12 882	12 882	12 882	12 882	12 882	0	0	11 656	11 656	0	0	0	0	3 087	3 087	3 087	3 087	3 087	7 273	3 384
Treasury Stock	1 769	1 769	3 465	4 860	4 860	4 860	4 860	4 913	4 913	4 950	7 179	19 141	22 007	21 884	21 773	21 737	26 628	26 557	26 476	21 631	21 631	13 762	23 754	33 739
Other Equity	0	0	0	0	0	0	0	0	0	0	0	6	36	74	109	121	136	158	184	1 703	1 703	14 865	14 865	14 865
Total Equity	52 432 N/A	59 607 +14%	63 038 +6%	67 942 +8%	74 531 +10%	93 099 +25%	97 405 +5%	102 901 +6%	109 584 +6%	117 260 +7%	119 880 +2%	112 739 -6%	112 983 +0%	126 042 +12%	148 063 +17%	169 695 +15%	193 467 +14%	197 904 +2%	197 474 0%	213 456 +8%	234 168 +10%	275 344 +18%	265 365 -4%	261 655 -1%
Total Liabilities & Equity	68 795 N/A	75 441 +10%	91 407 +21%	107 669 +18%	124 691 +16%	155 315 +25%	157 721 +2%	178 573 +13%	187 618 +5%	202 273 +8%	208 104 +3%	204 186 -2%	203 946 0%	209 306 +3%	220 736 +5%	227 573 +3%	241 847 +6%	252 639 +4%	244 151 -3%	269 033 +10%	332 496 +24%	406 557 +22%	419 901 +3%	425 166 +1%
Shares Outstanding
Common Shares Outstanding	12	12	12	12	12	13	13	13	13	13	13	13	12	12	12	12	12	12	12	12	12	13	13	12

Income Statement Balance Sheet Cash Flow Statement

Samjin Pharmaceutical Co Ltd
KRX:005500

Balance Sheet

Balance Sheet Decomposition
Samjin Pharmaceutical Co Ltd

Balance Sheet
Samjin Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Samjin Pharmaceutical Co Ltd KRX:005500

Balance Sheet

Balance Sheet Decomposition Samjin Pharmaceutical Co Ltd

Balance Sheet Samjin Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Samjin Pharmaceutical Co Ltd
KRX:005500

Balance Sheet Decomposition
Samjin Pharmaceutical Co Ltd

Balance Sheet
Samjin Pharmaceutical Co Ltd